NCT07206056 2026-04-16
TulmiSTAR-01
Novartis
Phase 1/2 Recruiting
Clinical Trials
6 trialsNCT04565665 2026-04-14
Study of Cord Blood Derived Mesenchymal Stem Cells for Treatment of Moderate, Severe or Critical Pneumonia
M.D. Anderson Cancer Center
Phase 1/2 Recruiting
NCT06097468 2026-04-13
Nisin in Oral Cavity Squamous Cell Carcinoma (OCSCC)
University of California, San Francisco
Phase 1/2 Recruiting
NCT06502691 2026-03-02
[18F]FTT Positron Emission Tomography for the Measurement of PARP Tumor Expression in Patients With Metastatic Breast Cancer
University of Washington
Phase 1/2 Recruiting
NCT05405595 2026-01-07
ADG126 in Combination With Pembrolizumab in Patients With Advanced/Metastatic Solid Tumors
Adagene Inc
Phase 1/2 Recruiting
NCT07053462 2025-07-08
CRISPR-Edited HLA Donor Kidney Transplant to Reduce Rejection Risk
AMERICAN ORGAN TRANSPLANT AND CANCER RESEARCH INSTITUTE LLC
Phase 1/2 Recruiting